Lacosamide
- Product NDC
- 47335-922
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lacosamide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA205031
- Marketing category
- ANDA
- Substance
- LACOSAMIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 47335-922-18 | 1000 TABLET, FILM COATED in 1 BOTTLE (47335-922-18) | 20220319 | | No | Historical |
| 47335-922-82 | 180 TABLET, FILM COATED in 1 BOTTLE (47335-922-82) | 20220319 | | No | Historical |
| 47335-922-86 | 60 TABLET, FILM COATED in 1 BOTTLE (47335-922-86) | 20220319 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 2098d3a5-776e-4b52-8ade-80a3ab7b3de7 | These highlights do not include all the information needed to use LACOSAMIDE TABLETS safely and effectively. See full prescribing information for LACOSAMIDE TABLETS. LACOSAMIDE tablets, for oral use, CV Initial U.S. Approval: 2008 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2024-10-14 | Human Prescription Drug Label | 13 |